IP Library Granted Patent US 9,725,746
Granted Patent B2
US 9,725,746 · App. 14/649,414 · Granted Aug 8, 2017

Producing amines and diamines from a carboxylic acid or dicarboxylic acid or a monoester thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,725,746
App. No.
14/649,414
Granted
Aug 8, 2017
Kind
B2
Abstract

The invention relates to a whole-cell catalyst which expresses a recombinant α-dioxygenase or the combination of a recombinant fatty acid reductase and a phosphopantetheinyl transferase which phosphopantetheinylates the fatty acid reductase, and which expresses, in addition to the α-dioxygenase and/or the combination of fatty acid reductase and phosphopantetheinyl transferase, a transaminase, wherein the phosphopantetheinyl transferase and/or transaminase is preferably recombinant; and also to a process for converting a carboxylic acid or dicarboxylic acid or a monoester thereof to an amine or diamine, comprising the steps of contacting the carboxylic acid or dicarboxylic acid or the monoester thereof with a phosphopantetheinylated fatty acid reductase or an α-dioxygenase and contacting the product with a transaminase.

Claims (24)

1. A whole-cell catalyst, comprising heterologous expression of: a combination of a recombinant fatty acid reductase and a phosphopantetheinyl transferase capable of phosphopantetheinylating the fatty acid reductase; and a transaminase, wherein the recombinant fatty acid reductase and the phosphopantetheinyl transferase, and the transaminase, are expressed in the whole-cell catalyst, and wherein the whole-cell catalyst is a microorganism.

2. The whole-cell catalyst according to claim 1 , further comprising:

an amino acid dehydrogenase expressed in the whole-cell catalyst.

3. The whole-cell catalyst according to claim 1 , further comprising:

an alkane hydroxylase expressed in the whole-cell catalyst.

4. The whole-cell catalyst according to claim 1 , further comprising:

a polypeptide of the AlkL family expressed in the whole-cell catalyst.

5. The whole-cell catalyst according to claim 1 , further comprising:

an alcohol dehydrogenase expressed in the whole-cell catalyst.

6. The whole-cell catalyst according to claim 1 , wherein an activity of at least one enzyme involved in β-oxidation is reduced as compared to an activity of the at least one enzyme in the wild type of the whole-cell catalyst.

7. The whole-cell catalyst according to claim 1 , wherein an activity of BioH is reduced or elevated as compared to an activity of BioH in the wild type of the whole-cell catalyst.

8. The whole-cell catalyst according to claim 1 , wherein an activity of FadL is elevated as compared to an activity of FadL in the wild type of the whole-cell catalyst.

9. A reaction mixture, comprising:

the whole-cell catalyst according to claim 1 in an aqueous solution; and

a carboxylic acid, a dicarboxylic acid, or a monoester thereof having the formula (I):

R 1 -A-COOR 2   (I),

wherein R 1 is —H or COOR 3 ,

R 2 and R 3 are each independently selected from the group consisting of H, methyl, ethyl and propyl, with the proviso that at least one of the radicals R 2 and R 3 is H, and

A is an unbranched, branched, linear, cyclic, substituted or unsubstituted hydrocarbon group having at least four carbons.

10. The whole-cell catalyst according to claim 1 , wherein at least one of the phosphopantetheinyl transferase and the transaminase is recombinant.

11. The whole-cell catalyst according to claim 1 , further comprising:

at least one of a recombinant amino acid dehydrogenase, a recombinant alkane hydroxylase, a recombinant polypeptide of the AlkL family, and a recombinant alcohol dehydrogenase, expressed in the whole-cell catalyst.

12. The whole-cell catalyst according to claim 1 , wherein the recombinant fatty acid reductase is encoded by a gene having at least 70% sequence identity to the nucleotide sequence of SEQ ID NO: 1, the phosphopantetheinyl transferase is encoded by a gene having at least 70% sequence identity to the nucleotide sequence of SEQ ID NO: 2, and the transaminase is encoded by a gene having at least 70% sequence identity to the nucleotide sequence of SEQ ID NO: 12.

13. The whole-cell catalyst according to claim 1 , further comprising: an alanine dehydrogenase expressed in the whole-cell catalyst and having at least 95% sequence identity to the nucleotide sequence of SEQ ID NO: 11, wherein the recombinant fatty acid reductase is encoded by a gene having at least 95% sequence identity to the nucleotide sequence of SEQ ID NO: 1, the phosphopantetheinyl transferase is encoded by a gene having at least 95% sequence identity to the nucleotide sequence of SEQ ID NO: 2, and the transaminase is encoded by a gene having at least 95% sequence identity to the nucleotide sequence of SEQ ID NO: 12.

Assignments (2)
CHANGE OF NAME Recorded Jan 31, 2020
From: EVONIK DEGUSSA GMBH
To: EVONIK OPERATIONS GMBH
Reel/Frame 051765/0166 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2015
From: SCHAFFER, STEFFEN; CORTHALS, JASMIN; WESSEL, MIRJA; HENNEMANN, HANS-GEORG; HAEGER, HARALD; VOLLAND, MICHAEL; ROOS, MARTIN
To: EVONIK DEGUSSA GMBH
Reel/Frame 035778/0900 →